Status:
COMPLETED
Immune and Physical Recovery Following Cesarean Delivery
Lead Sponsor:
Stanford University
Conditions:
Cesarean Delivery
Eligibility:
FEMALE
18-50 years
Brief Summary
Pregnancy results in an altered immune state compared to the nonpregnant population. A significant proportion of women undergoing cesarean delivery recover poorly. The first step to determining whethe...
Detailed Description
Variations will be evaluated in baseline and postpartum leukocyte subset distribution and singling pathways within leukocyte subsets (including response to surgery) in women undergoing elective cesare...
Eligibility Criteria
Inclusion
- elective cesarean delivery at Lucile Packard Hospital
- age \>20 to \<50 years old,
- single pregnancy term
- gestational age 37-41 weeks pregnancy,
- elective cesarean delivery,
- spinal or combined spinal-epidural anesthesia as primary anesthesia mode,
- multimodal analgesia regimen (including intrathecal morphine and regular acetaminophen and NSAIDs), single center at Stanford.
- ASA grade 1 or 2.
- gestational diabetes (not requiring insulin or diabetes medications and pre-eclampsia (without severe features) will be included.
- ethnic background: all ethnic backgrounds will be included gender: pregnant women only
Exclusion
- refusal to participate
Key Trial Info
Start Date :
November 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 23 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04358757
Start Date
November 22 2019
End Date
December 23 2023
Last Update
March 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305